Buparid/PARI SINUS

· Pari Pharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buparid/PARI SINUS, covering 2022-04-12 to 2022-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis [Phase 1, Phase 2]